Teleflex closes $45M ortho sale

Teleflex Medical ($TFX) closed a deal to unload its OEM orthopedics business, selling the unit to Tecomet for $45.2 million.

The unit brought in $36 million for Teleflex last year and sells the Beere Medical and SMD product lines, offering surgical tools, micro-machines and spinal implants, among other devices. The divestment is part of Teleflex's continued efforts to refocus on marketable products and late-stage techs, the company has said, and the devicemaker has done just that with its recent M&A spree.

First, Teleflex spent $30 million on Semprus BioSciences, an MIT spinout that markets a polymer coating for implantable devices. Then the company dropped $15 million on Hotspur Technologies, taking up that company's three 501(k)-cleared, CE marked catheters. This week, Teleflex splurged on LMA International, a maker of laryngeal masks, putting down $276 million in a deal expected to close in the fourth quarter.

CEO Benson Smith said the company's deal-packed summer was designed to expand Teleflex's product portfolio, saying the LMA deal alone will create a respiratory and anesthesia unit worth $530 million in sales. The company said the buyouts will increase its earnings per share by 3 cents to 4 cents this year and 35 cents to 40 cents in the next.

- read Teleflex's release

Like what you're reading?
Click here to get more news like this delivered to your inbox every day >>

Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.